NCT00001427
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +12 more
- Locations
-
- National Cancer Institute (NCI) Bethesda, Maryland, United States
Clinical trial condition
Ovarian Neoplasms
Explore clinical trials studying Ovarian Neoplasms. Study availability and eligibility vary by location and protocol.
2,333 public trials
507 recruiting studies
Ovarian Neoplasms trial results
NCT00001383
- Conditions
- Adenocarcinoma, Adnexal Diseases, Breast Cancer, +35 more
- Locations
-
- National Cancer Institute (NCI) Bethesda, Maryland, United States
NCT00090389
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +20 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
Completed
Phase II Study of Modified Triple Doublet Therapy in Women With Newly Diagnosed Mullerian Carcinoma
NCT00157560
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
Completed
Treatment for Patients With Gynecological Malignancies Who Suffer From Anemia Due to Chemotherapy
NCT00121030
- Conditions
- Adnexal Diseases, Anemia, Endocrine Gland Neoplasms, +18 more
- Locations
-
Not specified
NCT00539669
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +12 more
- Locations
-
- Sanofi-Aventis Seoul, South Korea
NCT00190697
- Conditions
- Adnexal Diseases, Breast Cancer, Breast Diseases, +22 more
- Locations
-
- For information regarding investigative sites for this clinical trial, call 1-877- CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST), or contact your personal physician Houston, Texas, United States
NCT00109096
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Brussels, Belgium
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Leuven, Belgium
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Berlin, Germany
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Erlangen, Germany
NCT00080041
- Conditions
- Adnexal Diseases, Breast Diseases, Breast Neoplasms, +26 more
- Locations
-
- University of Rochester Cancer Center Rochester, New York, United States
NCT00191607
- Conditions
- Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +20 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. St Louis, Missouri, United States